21 results
8-K
EX-10.3
PLSE
Pulse Biosciences Inc
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND WILL NOT INTERFERE IN ANY WAY … ) for purposes of the Option, Participant’s engagement as a Service Provider will be considered terminated as of the date Participant is no longer
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
11 May 23
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
4:15pm
engagement with FDA to finalize the regulatory path for the device.
Continued development across several preclinical studies for the Company’s nsPFA
8-K
EX-99.1
grhv2m5t 4w
10 Aug 22
Pulse Biosciences Reports Second Quarter 2022 Financial Results
4:15pm
8-K
EX-10.1
72onmddtrls
10 Jun 21
Other Events
4:41pm
8-K
EX-99.1
521d 1pul
10 Aug 20
Pulse Biosciences Reports Second Quarter 2020 Financial Results
4:27pm
CORRESP
bxem1
14 Apr 20
Correspondence with SEC
12:00am
8-K12B
EX-3.4
7z0z0m2tdy7b
18 Jun 18
Notification of registration of securities
4:55pm
8-K12B
EX-10.1
e6qhe5s xaa
18 Jun 18
Notification of registration of securities
4:55pm
10-K
EX-10.1
g6qbtx6 xe
20 Mar 17
Annual report
12:00am